Titrated THC:CBD Improves Pain and Spasticity Compared to Placebo Over 12 Weeks for Resistant MS
Sativex as add-on therapy vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trialInt J Neurosci. 2018 Sep 13:1-10.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE